Mauro Ferrari
CIK: 0001506045
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARROWHEAD PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 26, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct7.5K shares at avg. $70.00$527K - Dec 16, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct7.8K shares- - Nov 28, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct8.8K shares at avg. $56.39$493K - Dec 18, 2024ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct16.7K shares at avg. $22.99$385K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 26, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 7,530 | $70.00 | $527,100 | Direct |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 7,819 | - | - | Direct |
| Nov 28, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 8,750 | $56.39 | $493,413 | Direct |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 16,733 | $22.99 | $384,692 | Direct |
1-4 of 4 transactions
About Ferrari Mauro
Ferrari Mauro (SEC CIK 0001506045) files insider reports with the SEC as Director of ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
Signal8 holds 4 ownership filings by Ferrari Mauro, all Form 4s, filed between Dec 20, 2024 and Dec 30, 2025. Those filings report 4 transactions, from Dec 18, 2024 to Dec 26, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Ferrari Mauro's filings is in PASADENA, CA.
Recent filings by Ferrari Mauro
Other insiders filing for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
- OLUKOTUN ADEOYE Y, Director
- PERRY MICHAEL S, Director
- Cohen Matthew Gregory, Director
- Lu Hongbo, Director
- Apel Daniel Joseph, Chief Financial Officer
- Hamilton James C, Chief Medical Officer